Two Sigma Advisers’s China Pharma Holdings CPHI Stock Holding History

Two Sigma Advisers’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-46	Closed	-$2.2K	–	2611
2022 Q4	$2.2K	Hold	46	–	–	﹤0.01%	2491
2022 Q3	$3K	Sell	46 -1	-2%	-$99	﹤0.01%	2508
2022 Q2	$5K	Sell	47 -9	-16%	-$1.2K	﹤0.01%	2607
2022 Q1	$11K	Sell	56 -7	-11%	-$1.46K	﹤0.01%	2692
2021 Q4	$15K	Buy	63 +35	+125%	+$9.55K	﹤0.01%	2558
2021 Q3	$8K	Buy	+28	New	+$9.95K	﹤0.01%	2415

Other funds holding CPHI

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

FCT

First Community Trust Dubuque, Iowa $221M AUM 48.25% 1-Year Est. Return

Two Sigma Advisers's CPHI Position: Q1 2023 in Review

Two Sigma Advisers sold out of China Pharma Holdings (CPHI) in Q1 2023, closing a stake of 46 shares — an estimated $2.2K sold.

Two Sigma Advisers first reported a position in CPHI in Q3 2021 and held it in 6 quarters. The position peaked at $15K in Q4 2021. 4 funds tracked by Wall St. Rank hold CPHI as of Q1 2023.

Two Sigma Advisers reported no remaining China Pharma Holdings position as of Q1 2023 after selling out during the quarter.
Two Sigma Advisers sold 46 China Pharma Holdings shares in Q1 2023, an estimated $2.2K.
Two Sigma Advisers first reported a position in China Pharma Holdings in Q3 2021 and held it in 6 quarters.
Two Sigma Advisers's China Pharma Holdings position peaked at $15K in Q4 2021.
4 funds tracked by Wall St. Rank held China Pharma Holdings as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.